• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Atara Biotherapeutics, Inc. - Common Stock (NQ:ATRA)

    6.085 -0.595 (-8.91%)
    Streaming Delayed Price Updated: 3:36 PM EDT, Mar 10, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 527,778
    Open 6.450
    Bid (Size) 6.080 (200)
    Ask (Size) 6.170 (400)
    Prev. Close 6.680
    Today's Range 6.050 - 7.050
    52wk Range 3.920 - 19.14
    Shares Outstanding 101,102,152
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Top stock movements in today's session. ↗
    Via Chartmill
    News headline image
    The $1.35 Trillion Wall: Why Small-Caps are Faltering as the S&P 500 Defies Gravity
    As of March 9, 2026, the long-predicted "reckoning" for American small-cap stocks has officially arrived. While the broader market remains buoyed by the resilient "Magnificent Seven" and a robust AI... 
    Via MarketMinute
    Topics Artificial Intelligence Bonds Economy

    Performance

    YTD
    -65.8%
    -65.8%
    1 Month
    +22.2%
    +22.2%
    3 Month
    -59.6%
    -59.6%
    6 Month
    -50.0%
    -50.0%
    1 Year
    -1.2%
    -1.2%

    More News

    Read More
    Gapping stocks in Monday's session ↗
    Via Chartmill
    News headline image
    ATRA Rises On Pushing For Meeting With FDA On Rare Disease Drug Rejection ↗
    Via Stocktwits
    News headline image
    Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel
    From Atara Biotherapeutics, Inc.
    Via Business Wire
    News headline image
    Atara Biotherapeutics Provides a Business Update
    From Atara Biotherapeutics, Inc.
    Via Business Wire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    FDA Reversal Sends Atara Biotherapeutics into Tailspin: Stock Plummets 67% on Second CRL for Tabelecleucel
    Via MarketMinute
    Topics Bankruptcy
    The trading volume of these stocks is deviating from the norm in today's session. ↗
    Via Chartmill
    Keep an eye on the top gainers and losers in Tuesday's session. ↗
    Via Chartmill
    Unusual volume stocks are being observed in Tuesday's session. ↗
    Via Chartmill
    Keep an eye on the top gainers and losers in Monday's session. ↗
    Via Chartmill
    Top stock movements in today's session. ↗
    Via Chartmill
    News headline image
    ATRA Stock Nearly Halves In Value After FDA Refuses Approval For Immunotherapy: Retail Sees ‘Big Fight Back’ ↗
    Via Stocktwits
    Gapping stocks in Monday's session ↗
    Via Chartmill
    Top movers in Monday's pre-market session ↗
    Via Chartmill
    News headline image
    Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO™ (tabelecleucel)
    From Atara Biotherapeutics, Inc.
    Via Business Wire
    News headline image
    Small-Cap Renaissance: Russell 2000 Scales New Heights While Big Tech Stumbles
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    Small-Cap Slump: Russell 2000 Tumbles as Sticky Inflation Data Revives 'Higher-for-Longer' Fears
    Via MarketMinute
    Topics Artificial Intelligence Economy Stocks
    News headline image
    Atara Biotherapeutics Announces Third Quarter Financial Results and Operational Progress
    From Atara Biotherapeutics, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
    Via Benzinga
    News headline image
    4 Biotechnology Stocks That Outshine In Momentum Amid Strong Technicals ↗
    Via Benzinga
    News headline image
    Atara Biotherapeutics Announces Changes to Its Board of Directors
    From Atara Biotherapeutics, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Atara Biotherapeutics, Inc. - Common Stock publicly traded?
    Yes, Atara Biotherapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Atara Biotherapeutics, Inc. - Common Stock trade on?
    Atara Biotherapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Atara Biotherapeutics, Inc. - Common Stock?
    The ticker symbol for Atara Biotherapeutics, Inc. - Common Stock is ATRA on the Nasdaq Stock Market
    What is the current price of Atara Biotherapeutics, Inc. - Common Stock?
    The current price of Atara Biotherapeutics, Inc. - Common Stock is 6.085
    When was Atara Biotherapeutics, Inc. - Common Stock last traded?
    The last trade of Atara Biotherapeutics, Inc. - Common Stock was at 03/10/26 03:36 PM ET
    What is the market capitalization of Atara Biotherapeutics, Inc. - Common Stock?
    The market capitalization of Atara Biotherapeutics, Inc. - Common Stock is 615.21M
    How many shares of Atara Biotherapeutics, Inc. - Common Stock are outstanding?
    Atara Biotherapeutics, Inc. - Common Stock has 615M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.